A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Duchene Muscular Dystrophy

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Arkansas Children's Research Institute, Little Rock, Arkansas, United States

    Contact: Study coordinator (Domencia Hunter) · hunterdj@archildrens.org · 973-932-9211
    Contact: Principal Investigator (Aravindhan Veerapandiyan)
  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Margaret Martinez) · mbmartin@childrensnational.org · 202-476-2431
    Contact: Principal Investigator (Sarah Wright, DO)
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Raven Hill) · rhill@luriechildrens.org · 312-227-2937
    Contact: Principal Investigator (Bridget McGowan)
  • Boston Children's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Gerald Mastellone) · Gerald.mastellone@childrens.harvard.edu · 857-218-4677
    Contact: Principal Investigator (Partha Ghosh, MD)
  • University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

    Contact: Study coordinator (Sarah Figueira) · sarah.figueira@umassmed.edu · (508) 856-1604
    Study coordinator · dmdprogram@umassmemorial.org
    Contact: Principal Investigator (Stephen Chrzanowski)
  • Columbia University Medical Center, New York, New York, United States

    Contact: Study coordinator (Kimberly Berry) · kb2996@cumc.columbia.edu · 212-342-3038
    Contact: Principal Investigator (Divya Jayaraman)
  • Duke University / Lenox Baker Children's Hospital, Durham, North Carolina, United States

    Contact: Study coordinator (Brittany Nave) · brittany.nave@duke.edu · 919-684-8087
    Contact: Principal Investigator (Natalie Katz, MD)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Nadee Dayananda) · dayanand@ohsu.edu · 503-418-0949
    Contact: Principal Investigator (Erika Finanger, MD)
  • Seattle Children's Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Macarena Racciatti) · macarena.racciatti@seattlechildrens.org · 206-995-6847
    Contact: Principal Investigator (Alicia Henriquez)